Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

19 (USD) • At close November 7, 2023
Bedrijfsnaam Intercept Pharmaceuticals, Inc.
Symbool ICPT
Munteenheid USD
Prijs 19
Beurswaarde 794,694,000
Dividendpercentage 0%
52-weken bereik 8.82 - 21.86
Industrie Biotechnology
Sector Healthcare
CEO Mr. Jerome B. Durso
Website https://www.interceptpharma.com

An error occurred while fetching data.

Over Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in

Vergelijkbare Aandelen

Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd.

NNOX

6.76 USD

Cullinan Oncology, Inc. logo

Cullinan Oncology, Inc.

CGEM

11.6 USD

Inhibrx, Inc. logo

Inhibrx, Inc.

INBX

14.6 USD

ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc.

ANIP

53.35 USD

Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc.

CRBU

1.8 USD

Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

IPSC

1.1 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)